Bone Biologics Corp. (BBLG) vs Carisma Therapeutics Inc. (CARM)
Bone Biologics Corp. and Carisma Therapeutics Inc. are both Biotechnology companies. Carisma Therapeutics Inc. is the larger, with a market value of $1.5M against $1.4M — 1.1× the size. Carisma Therapeutics Inc. has the higher net margin (14.4% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Carisma Therapeutics Inc. leads on 6 and Bone Biologics Corp. on 4.
Valuation
Profitability
| Metric | BBLG | CARM | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 65.16% |
| Operating margin | 0.00% | 19.36% | 0.00% |
| Net margin | 0.00% | 14.36% | 0.00% |
| Free cash flow margin | 0.00% | (38.79%) | 0.00% |
| Return on equity | (54.96%) | (134.11%) | (57.72%) |
| Return on assets | (50.55%) | 33.09% | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack